In colon cancer, SMAD4 deficiency results in increased MMP9 expression in colon cancer cells, amplifying the expression of the hypoxia-inducible factor GLUT1, thereby promoting aerobic glycolysis processes [38]. This evidence concerns the gene SMAD4 and colonic neoplasm.